EVOK Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.10%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $179.99

Evoke Pharma Insider Trading History Chart

Evoke Pharma Share Price & Price History

^$3.85

▲ +0.17 (4.62%)

As of 03/13/2025 05:00 PM ET

Days: 30 | 90 | 365

Evoke Pharma Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/28/2025	Nantahala Capital Management,	Major Shareholder	Sell	41	$4.39	$179.99	148,153

SEC Filings (Institutional Ownership Changes) for Evoke Pharma (NASDAQ:EVOK)

Institutional Buying and Selling by Quarter

Evoke Pharma Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/14/2025	Nantahala Capital Management LLC	148,194	$0.66M	0.0%	+163.5%	9.946%
11/14/2024	Corsair Capital Management L.P.	11,667	$56K	0.0%	N/A	1.425%
11/9/2021	BlackRock Inc.	175,559	$0.23M	0.0%	+9.2%	0.541%
11/2/2021	Raymond James Financial Services Advisors Inc.	108,545	$0.14M	0.0%	-8.9%	0.335%
8/17/2021	Worth Venture Partners LLC	397,742	$0.55M	0.2%	+18.2%	1.229%
8/16/2021	Sabby Management LLC	47,431	$65K	0.0%	N/A	0.147%
8/13/2021	Geode Capital Management LLC	195,760	$0.27M	0.0%	+22.4%	0.605%
8/13/2021	Vanguard Group Inc.	1,120,178	$1.53M	0.0%	-1.5%	3.460%
8/12/2021	AIGH Capital Management LLC	1,701,185	$2.33M	0.4%	+18.7%	5.255%
5/20/2021	Axiom Investment Management LLC	17,500	$32K	0.0%	N/A	0.054%
5/19/2021	Worth Venture Partners LLC	336,516	$0.62M	0.3%	N/A	1.040%
5/18/2021	Morgan Stanley	723,897	$1.33M	0.0%	+43.6%	2.236%
5/18/2021	Jane Street Group LLC	18,044	$33K	0.0%	N/A	0.056%
5/13/2021	Axiom Investment Management LLC	17,500	$32K	0.0%	N/A	0.054%
5/12/2021	UBS Group AG	31,757	$58K	0.0%	+1,709.5%	0.098%
5/7/2021	BlackRock Inc.	150,891	$0.28M	0.0%	+8.2%	0.466%
4/9/2021	Pure Financial Advisors Inc.	17,647	$32K	0.0%	N/A	0.055%
2/24/2021	Virtu Financial LLC	18,335	$47K	0.0%	N/A	0.069%
2/10/2021	Renaissance Technologies LLC	187,276	$0.48M	0.0%	+739.8%	0.710%
2/9/2021	Wells Fargo & Company MN	25,117	$65K	0.0%	+17,840.7%	0.095%
2/5/2021	BlackRock Inc.	139,474	$0.36M	0.0%	+8.7%	0.529%

Data available starting January 2016

See Full Table

Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It offers Gimoti, a metoclopramide nasal spray to treat symptoms associated with acute and recurrent diabetic gastroparesis in adults. The company markets its products to gastroenterologists, internal medicine specialists, primary care physicians, and select health care providers. Evoke Pharma, Inc. was incorporated in 2007 and is headquartered in Solana Beach, California.

Today's Range

Now: $3.85

$3.67

$3.91

50 Day Range

MA: $4.55

$3.62

$5.40

52 Week Range

Now: $3.85

$3.44

$12.32

Volume

18,141 shs

Average Volume

10,970 shs

Market Capitalization

$5.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.12

Who are the company insiders with the largest holdings of Evoke Pharma?: Evoke Pharma's top insider investors include:
Nantahala Capital Management, (Major Shareholder)
Learn More about top insider investors at Evoke Pharma.
Who are the major institutional investors of Evoke Pharma?: Evoke Pharma's top institutional investors include:
Nantahala Capital Management LLC — 9.95%
Concourse Financial Group Securities Inc. — 0.00%
Learn More about top institutional investors of Evoke Pharma stock.
Which institutional investors are buying Evoke Pharma stock?: In the last quarter, EVOK stock was acquired by institutional investors including:
Nantahala Capital Management LLC